Skip to main content
. Author manuscript; available in PMC: 2008 Apr 27.
Published in final edited form as: Neuroscience. 2007 Feb 22;146(1):330–339. doi: 10.1016/j.neuroscience.2007.01.023

Figure 2.

Figure 2

Effects of CPO exposure (0.1-10.0 μM) on immunoreactivity (IR) of MAP-2a/b (as % control) in hippocampal slice culture subregions 1, 3, and 7 days after the start of CPF exposure. Reductions in MAP-2a/b were evident in the primary neuronal layers of each region beginning on day 1 (≥1.0 μM) and progressively worsened in the pyramidal cell layers of CA1 and CA3 (≥0.1 μM). * = P < 0.05 vs control.